Tirzepatide Microdosing

• FormInjectable (multi-dose vial) + syringes
• OptionsLower-dose program. Formulation and dosing individualized by the prescribing provider
• AvailabilityAvailability varies by state and pharmacy.

The most common side effects are nausea, vomiting, diarrhea, decreased appetite, and constipation, most often around dose increases. Tirzepatide caused thyroid C-cell tumors in animal studies, and it must not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It has also been associated with pancreatitis, gallbladder disease, and kidney injury from severe dehydration, and taking it with insulin or a sulfonylurea increases the risk of low blood sugar. Do not use tirzepatide during pregnancy, and be aware it can make oral birth control pills less effective for a period after starting or increasing the dose. Seek emergency care for severe, persistent abdominal pain, with or without vomiting, which can be a sign of pancreatitis, and contact your provider promptly about a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath.

What if I’m not prescribed?

You’re refunded everything except a $30 provider visit fee, which covers the licensed provider’s review of your health information. A provider decides whether a treatment is right for you; a prescription is never guaranteed.

Who is my provider?

A physician, nurse practitioner or physician assistant from an independent, physician-led medical group licensed in your state. They make every medical decision. The groups are listed on our Standards page.

Can I message my provider?

Yes. Message your provider in your patient portal. It isn’t for emergencies: if it’s urgent, call 911.

What does compounded mean?

Compounded medications are prepared by a licensed pharmacy for one patient, are not FDA approved, and are not interchangeable with a brand-name drug.

How do refills work?

Request a refill from your patient portal. Your provider decides whether a follow-up visit is needed.

Compounded GLP-1 medications should only be considered when an individual patient’s medical needs cannot be met by an FDA-approved medication. An independent provider and the dispensing pharmacy must determine whether a prescription meets applicable compounding requirements.

A lower price, a different dose, or an added ingredient does not by itself establish that a compounded product qualifies for an exception to restrictions on copying commercially available drugs. Where a patient-specific significant difference is the basis, the prescriber must determine and document it.

“Microdosing” is a program label, not an FDA-approved dosing regimen. It does not establish that treatment is safer or has fewer side effects. Dosing is determined by the independent provider, not selected from a website menu.

Read the FDA’s compounding guidance ↗